Efeitos do Ziclague na espasticidade: melhora na funcionalidade e cinemática da marcha

Abstract

Introduction: Multiple Sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system. The spasticity present in these patients can limit the functionality, gait, and quality of life, for this reason, its reduction is fundamental. The Ziclague, deriving from the Alpinia Zerumbet oil, is used in muscle relaxation and tonus normalization. Objective: Measure immediate and long term effects of the Ziclague on the linear and angular variables of gait, and the functionality on a patient with MS. Methods: Pilot intervention study on a person with spasticity and limitations on the gait. Results: The measurement of muscle tone showed decrease of the spasticity in the hip adductors bilaterally, hamstrings, and plantiflexors on the right, as well as increase of the muscle strength in the hip adductors and plantiflexors. The gait analysis showed improvement in all the linear and angular kinematic parameters after the application of the Ziclague, with emphasis on the steps 1 to 5. Regarding quality of life, an improvement was observed in the fields: functional capacity, limitation by physical aspects, pain, social aspects, and mental health. In the fatigue evaluation, there was no difference in the total score. Conclusion: The Ziclague was effective in the modulation of the spastic tonus, proving its immediate and long term effect. There was an improvement in the gait kinematics, resulting from the greater muscle recruitment acquired, and in the quality of life.(sic)